GSK AUDITORY TRANSLATIONAL SCIENCE WORKSHOP
subsequent to the ARO 37th Mid Winter Meeting
San Diego, CA, USA
12.00 – 17.00, February 26th 2014
GlaxoSmithKline (GSK) R&D has an increasing interest in the emerging science and potential for drug discovery and development for diseases of the ear and auditory system. Scientists from GSK shall be attending the ARO 37th Mid Winter Meeting in San Diego, which closes at midday on February 26th and GSK has organised a half day Diseases of the Ear Science Workshop at the end of this event on the afternoon of February 26, 2014 at the Grand Manchester Hyatt, to discuss the latest advances presented at the ARO event and explore with the auditory research community the science being developed around the world, the medical and patient need and the potential therapeutic opportunities and paths to medicines that might exist.
To help GSK understand the auditory landscape and potential translational opportunities, GSK has organised a half day workshop inviting scientific leaders from diverse disease areas including regenerative approaches, tinnitus, inner ear therapeutic delivery, vestibular disorders and presbycusis to present an overview of key advances within and beyond their research. The objective is to have discussions and debate involving leaders from each field, so that it will help to eventually translate the scientific progress into novel therapeutics for the treatment of the auditory diseases.
GSK plans to run this as an open workshop, with lunch available at noon with the program starting at 12.30, and welcome members of the auditory science community to join us for this event. To register for the event and receive details, please RSVP no later than February 2nd to firstname.lastname@example.org. Space will be limited by size of venue and to maximize group interaction.
The workshop will be engaging and productive as as outlined below:
- Regeneration of sensory hair cells – Andy Forge (UCL Ear Institute)
- Tinnitus – David McAlpine (UCL Ear Institute)
- Presbycusis – Karen Steel (King’s College London)
- Menierie’s, Inner Delivery & Pharmacokinetics - Alec Salt (Washington University)
- Open panel discussion to include speakers and Charles Liberman (Massachusetts Eye and Ear Infirmary)
TINNITUS & HYPERACUSIS THERAPY MASTERCLASS
Specialist training for tinnitus and hyperacusis therapy
Birbeck College, University of London, UK
March 3 - 7, 2014
Course Tutor: Hashir Aazh, NIHR Research Fellow, University of London
This 5-day international course is designed for those who are keen to specialise in tinnitus and hyperacusis therapy and includes many practical sessions. Participants will be provided with the specialist skill, knowledge and tools which are essential for developing or expanding their Tinnitus service. In addition, this course provides a range of lectures on the most recent research evidence on tinnitus and hyperacusis.
Detailed Information: Meeting Website
22TH ANNUAL MANAGEMENT OF THE TINNITUS PATIENT COURSE
University of Iowa, USA
June 13 - 14, 2014
This conference is intended for otologists, audiologists, psychologists, and nurses who provide clinical management services for patients with tinnitus. The conference will also provide information to patients who have tinnitus, their family and friends, but it will NOT include individual diagnosis and treatment. The purpose of this conference is to provide a review of current evaluation and management strategies for the treatment of tinnitus. Upon completion of the program, the participant will be able to discuss the management of tinnitus and the tinnitus patient.
To see the complete program and to register go to:
THE COURSE ON TINNNITUS RETRAINING THERAPY (TRT) FOR MANAGEMENT OF TINNITUS & HYPERACUSIS
Columbia, Maryland, USA
April 10 – 12 (Thu - Sat), 2014
The course is approved by AAA for 2.0 (Tier 1) CEUs. Canadian participants are eligible for 24 hours CEE from CASLPA.
The course is intended for participants who provide clinical management services for patients with tinnitus and/or hyperacusis. The purpose of the course is to teach the theoretical basis and clinical implementation of TRT, based on a neurophysiological model of tinnitus and hyperacusis, so the participants will be able to help patients utilizing this habituation-oriented approach.
This is an interactive course with small group of participants. At the end of the three days the participant should feel comfortable to start working with tinnitus and hyperacusis patients almost immediately. Extensive materials are provided.
If you are interested please contact Drs. Margaret & Pawel Jastreboff at www.tinnitus-pjj.com or JHDF2008@gmail.com, fax 443-218-4007 to receive detailed information.